期刊文献+

大剂量羟考酮控释片治疗重度癌痛的安全性及疗效的临床分析 被引量:6

下载PDF
导出
摘要 目的评价大剂量(≥1日150mg)奥施康定(羟考酮控释片)治疗晚期癌症重度疼痛的安全性和临床疗效。方法选择2008年12月~2011年12月就诊于我科的21例重度疼痛晚期癌症患者为研究组,25例轻、中度疼痛晚期癌症患者为对照组。研究组给予大剂量奥施康定(1日150mg~640mg)治疗,对照组采用一般剂量奥施康定(1日10mg~140mg)治疗,比较两组疼痛缓解率和不良反应情况。结果研究组和对照组总疼痛缓解率分别为95.3%和96.0%,两组间比较差异不具有统计学意义。研究组不良反应主要表现为便秘占42.8%,其次是纳差、厌食、腹胀占33.3%,恶心及呕吐、嗜睡、头晕、排尿困难等分别占14.3%、14.3%、9.5%和9.5%,对照组便秘占32.0%,纳差、厌食、腹胀占16.0%,恶心呕吐、嗜睡、头晕、排尿困难等分别占12.0%、8.0%、4.0%和4.0%,两组间差异不具有统计学意义。结论大剂量奥施康定治疗重度癌痛的安全性良好,不良反应并没有随剂量加大而明显增加,同时临床疗效显著,总疼痛缓解率达95.3%,按个体化加大奥施康定剂量是治疗重度癌痛首选方法之一,值得临床推荐应用。
出处 《海峡药学》 2013年第8期110-113,共4页 Strait Pharmaceutical Journal
  • 引文网络
  • 相关文献

参考文献9

  • 1孙燕,顾慰萍.癌症疼痛三阶梯止痛指导原则[M].北京:中国协和医科大学联合出版社,2002,12-17.
  • 2于世英,邱红,马振山,陈嘉,张英,陈立正,王东林,马智勇.盐酸吗啡缓释片治疗癌症疼痛的临床疗效分析[J].中华医学杂志,2004,84(6):450-455. 被引量:33
  • 3Gilson A M, Joranson D E, Mauler M A. Improving state medical board policies .iofluence of a model [ J]. J Law Med Ethics, 2003,31 ( 1 ) : 119-129.
  • 4许德凤,王杰军,郑莹,李德录,王伟,卢伟.上海市癌症止痛现状调查[J].中国肿瘤,2001,10(7):389-392. 被引量:27
  • 5王奇璐.实用肿瘤内科学[M].北京:人民卫生出版社,2003,217.
  • 6Jamison R N, Raymond S A, Slawsby E A, et al. Opioid therapy for chronic noncancer back pain. A randomized prospective study [J]. Spine ( Phila Pa 1976 ), 1998,23 ( 23 ) : 2591-2600.
  • 7孙燕.肿瘤内科学[M]第2版.北京:人民卫生出版社,2003.180.
  • 8Watson C P, Mou|in D, WaR-Watson J, et ,,I. Controlled-release oxyc- one relieves neurepathic paln:a randomized controlled trial in pain- rul diabetic neuropathy[J]. Pain,2003,105(1-2) :71-78.
  • 9Ackerman S J,Mordin M,Reblando J,et aL Patient-reported utilization patterns of fenumyl tmnsdermal system and oxycedone hydrochloride ontreHed-release among patients with chronic nonmalignant pain[J]. J Manag Care Pharm,2(X)3,9(3) .223-231.

二级参考文献10

  • 1Yu SY. Sustained release morphine for cancer pain management. J Clinic Oncology, 1998,3:44-45.于世英.吗啡控释片治疗癌痛的临床研究.临床肿瘤学杂志1998,3:44-45.
  • 2Sun Y. Assesment the quality of life for cancer patients in China. In: SunY, Gu WP, eds Guideline for cancer pain relief by three steps. 2nd ed. Beijing: Beijing Medical University PublishingHouse, 2002. 100-101.孙燕.我国试行的肿瘤病人生活质量评分.见:孙燕
  • 3WHO. Medical nedd for opioid analgesics. In: WHO, ed. Achieving balance in national opioids control policy: guidelines for assessment. Geneva: WHO, 2000, 3-4.
  • 4Joranson DE, Ryan KM, Gilson AM, et al. Trends in medical useand abuse of opioid analgesics. JAMA, 2000, 283:1710-1714.
  • 5Klepstad P, Kaasa S, Jystad A, et al. Immediate- or sustainedrelease morphine for dose finding during start of morphine to cancer patients: a randomized, double-blind trial. Pain, 2003, 101:193-98.
  • 6Warfield CA. Controlled-release morphine tablets in patients with chronic cancer pain. A narrative review of controlled clinical trials. Cancer, 1998, 82:2299-2306.
  • 7Chemy NI. The management of cancer pain. CA Cancer J Clin, 2000, 50: 70-116.
  • 8Tassain V, Attal N, Fletcher D, et al. Long term effects of oral sustained release morphine on neuropsychological performance in patients with chronic non-cancer pain. Pain, 2003, 104:389-400.
  • 9Yu SY, Wang XS, Chen Y, et al. Special aspects of cancer pain management in a Chinese general hospital. Eur J Pain, 2001,5:15-20.
  • 10Wang XS, Li TD, Yu SY, et al. China: Status of pain and palliativecare. J Pain and Sympt Manage, 2002, 24: 177-179.

共引文献59

同被引文献51

  • 1施文,王永铭,李端,李少丽,颜敏,程能能,陈斌艳.对乙酰氨基酚与非甾体抗炎药治疗骨关节炎的疗效和安全性的观察[J].中国疼痛医学杂志,2004,10(6):327-331. 被引量:13
  • 2叶庆明,张华丹,卢君强,刘岩松.丁哌卡因用于小儿硬膜外术后镇痛[J].现代医院,2005,5(6):30-31. 被引量:1
  • 3何并文,邹小英.局部麻醉药的非麻醉作用[J].国外医学(麻醉学与复苏分册),1996,17(1):22-25. 被引量:25
  • 4汤钊猷.现代肿瘤学[M].3版.上海:复旦大学出版社,2011:890-931.
  • 5Hwang BY, Kwon JY, Lee DW, et al. A Randomized Clinical Trial of Nefopam versus Ketorolac Combined With Oxycodone in Patient-Controlled Analgesia after Gynecologic Surgery [ J ]. Int J Med Sci, 2015,12 ( 8 ) : 644-649. DOI: 10. 7150/ijms. 11828. eCollection 2015.
  • 6Fanelli G, Fanelli A. Developments in managing severe chronic pain : role of oxycodone-naloxone extended release [ J ]. Drug Des Devel Ther, 2015,9 (6) :3811-6381. DOI: 10. 2147/DDDT. $73561. eColleetion 2015.
  • 7Morton T, Franke R, Devarakonda K. Pooled post hoc analysis of population pharmacokinetics of oxycodone and acetaminophen fol- lowing a single oral dose of biphasic immediate-release/extended- release oxycodone/acetaminophen tablets [ J ]. Pain Pract, 2015, (9) :4587-4597. DOI: 10. 1111/papr. 12329.
  • 8Neelakantan H, Ward S J, Walker EA. Discriminative stimulus effects of morphine and oxycodone in the absence and presence of acetic acid in male and female C57B1/6 mice[Jl. Exp Clin Psy- chopharmacol, 2015, 23 ( 4 ) : 217-227. DOI: 10. 1037/ phaO000028.
  • 9钟颖,衡新华,杨文燕,毕春,陈同延.对乙酰氨基酚直肠给药用于小儿术后镇痛的临床观察[J].昆明医学院学报,2008,29(3):137-139. 被引量:7
  • 10刘灿坤,向东东,沈红星,李金牛,汲广成.加巴喷丁对癌症晚期疼痛患者的疗效观察[J].临床神经病学杂志,2008,21(3):215-215. 被引量:5

引证文献6

二级引证文献91

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部